In human alloreactive CD4+ T-cells, dichloroacetate inhibits aerobic glycolysis, induces apoptosis and favors differentiation towards the regulatory T-cell subset instead of effector T-cell subsets

被引:14
|
作者
Eleftheriadis, Theodoros [1 ]
Sounidaki, Maria [1 ]
Pissas, Georgios [1 ]
Antoniadi, Georgia [1 ]
Liakopoulos, Vassilios [1 ]
Stefanidis, Ioannis [1 ]
机构
[1] Univ Thessaly, Sch Med, Dept Nephrol, Mezourlo Hill, Larisa 41110, Greece
关键词
alloreactivity; dichloroacetate; T-cell; glycolysis; Th1; Th2; Th17; Treg; INDOLEAMINE 2,3-DIOXYGENASE; RENAL-TRANSPLANTATION; SUBPOPULATIONS; METABOLISM; ACTIVATION; INDUCTION; TOLERANCE;
D O I
10.3892/mmr.2016.4912
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Although kidney transplantation is the best therapy for end-stage renal disease, rejection remains a concern, and currently available immunosuppressive agents contribute to morbidity and mortality. Thus, novel immunosuppressive drugs are required. Dichloroacetate (DCA) is already used in the treatment of congenital lactic acidosis and characterized by limited toxicity. As DCA inhibits aerobic glycolysis, which is a prerequisite for CD4(+) T-cell proliferation and differentiation into effector T-cells, its possible immunosuppressive role in mixed lymphocyte reaction (MLR), a model of alloreactivity, was investigated. Glucose and lactate concentrations were measured in the supernatants, and cell proliferation was assessed immunoenzymatically. CD4(+) T-cells were then isolated from the MLRs and the expression of cleaved caspase-3, various enzymes involved in glycolysis, and the signature transcription factors of CD4(+) T-cell subsets were evaluated by western blotting. In MLRs, DCA decreased glucose consumption and aerobic glycolysis, while it exerted a negligible effect on cell proliferation. In CD4(+) T-cells, DCA induced apoptosis, and decreased the expression of glucose trasporter-1, hexokinase II, lactate dehydrogenase-A and phosphorylated pyruvate dehydrogenase, while it increased total pyruvate dehydrogenase. In addition, DCA increased the expression of transcription factor forkhead box P3, whereas it decreased the expression of T-box transcription factor TBX21, trans-acting T-cell-specific transcription factor GATA-3 and retinoic acid receptor related orphan receptor-gamma t. In conclusion, in alloreactive CD4(+) T-cells, DCA inhibits aerobic glycolysis, induces apoptosis and favors differentiation towards the regulatory T-cell subset. These characteristics render it a promising immunosuppressive agent in the field of transplantation.
引用
收藏
页码:3370 / 3376
页数:7
相关论文
共 50 条
  • [31] Tolerogenic Semimature Dendritic Cells Induce Effector T-cell Hyporesponsiveness by the Activation of Antigen-Specific CD4+ CD25+ T-Regulatory Cells
    Fu, Bi-mang
    He, Xiao-shun
    Yu, Si
    Hu, An-bin
    Ma, Yi
    Wu, Lin-wei
    Tam, Nga-lei
    Huang, Jie-fu
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2009, 7 (03) : 149 - 156
  • [32] Differences in coreceptor specificity contribute to alternative tropism of HIV-1 subtype C for CD4+ T-cell subsets, including stem cell memory T-cells
    Cashin, Kieran
    Paukovics, Geza
    Jakobsen, Martin R.
    Ostergaard, Lars
    Churchill, Melissa J.
    Gorry, Paul R.
    Flynn, Jacqueline K.
    RETROVIROLOGY, 2014, 11
  • [33] Constitutively active Stat5b in CD4+ T cells inhibits graft-versus-host disease lethality associated with increased regulatory T-cell potency and decreased T effector cell responses
    Vogtenhuber, Christine
    Bucher, Christoph
    Highfill, Steven L.
    Koch, Lisa K.
    Goren, Emily
    Panoskaltsis-Mortari, Angela
    Taylor, Patricia A.
    Farrar, Michael A.
    Blazar, Bruce R.
    BLOOD, 2010, 116 (03) : 466 - 474
  • [34] Diminished Pneumococcal-Specific CD4+ T-Cell Response is Associated With Increased Regulatory T Cells at Older Age
    He, Samantha W. J.
    van de Garde, Martijn D. B.
    Pieren, Daan K. J.
    Poelen, Martien C. M.
    Voss, Franziska
    Abdullah, Mohammed R.
    Hammerschmidt, Sven
    van Els, Cecile A. C. M.
    FRONTIERS IN AGING, 2021, 2
  • [35] Empagliflozin modulates CD4+ T-cell differentiation via metabolic reprogramming in immune thrombocytopenia
    Qin, Jing
    Liu, Qiang
    Liu, Anli
    Leng, Shaoqiu
    Wang, Shuwen
    Li, Chaoyang
    Ma, Ji
    Peng, Jun
    Xu, Miao
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 198 (04) : 765 - 775
  • [36] Interferon regulatory factor 8 integrates T-cell receptor and cytokine- signaling pathways and drives effector differentiation of CD8 T cells
    Miyagawa, Fumi
    Zhang, Hong
    Terunuma, Atshushi
    Ozato, Keiko
    Tagaya, Yutaka
    Katz, Stephen I.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (30) : 12123 - 12128
  • [37] Chloroquine inhibits human CD4+ T-cell activation by AP-1 signaling modulation
    Schmidt, Ralf L. J.
    Jutz, Sabrina
    Goldhahn, Katrin
    Witzeneder, Nadine
    Gerner, Marlene C.
    Trapin, Doris
    Greiner, Georg
    Hoermann, Gregor
    Steiner, Guenter
    Pickl, Winfried F.
    Burgmann, Heinz
    Steinberger, Peter
    Ratzinger, Franz
    Schmetterer, Klaus G.
    SCIENTIFIC REPORTS, 2017, 7
  • [38] Differential PI3Kδ Signaling in CD4+ T-cell Subsets Enables Selective Targeting of T Regulatory Cells to Enhance Cancer Immunotherapy
    Ahmad, Shamim
    Abu-Eid, Rasha
    Shrimali, Rajeev
    Webb, Mason
    Verma, Vivek
    Doroodchi, Atbin
    Berrong, Zuzana
    Samara, Raed
    Rodriguez, Paulo C.
    Mkrtichyan, Mikayel
    Khleif, Samir N.
    CANCER RESEARCH, 2017, 77 (08) : 1892 - 1904
  • [39] Neutralization of IL-4 reverses the nonresponsiveness of CD4+ T cells to regulatory T-cell induction in non-responder mouse strains
    Wang, Jun
    Han, Wanda G. H.
    Foks, Amanda C.
    Huizinga, Tom W. J.
    Toes, Rene E. M.
    MOLECULAR IMMUNOLOGY, 2010, 48 (1-3) : 137 - 146
  • [40] Basic science for the clinician 45 -: CD4+ T-Cell subsets of probable clinical consequence
    Sigal, Leonard H.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2007, 13 (04) : 229 - 233